The Cancer Institute Hospital Of JFCR /ID# 280140

Koto-ku, Tokyo 135-8550

1 studies enrolling now · 1 studies all time

What they study most

Metastatic Pancreatic Ductal Adenocarcinoma, PDAC

Studies at this site

• A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma — Recruiting now